Recent advances in veterinary vaccine adjuvants (Q35143257)

6 August 2017

Recent advances in veterinary vaccine adjuvants (English)

1 reference

6 August 2017

1 reference

Manmohan Singh

1

1 reference

PubMed ID

12782048

6 August 2017

Derek T O'Hagan

series ordinal

2

1 reference

6 August 2017

1 May 2003

1 reference

International Journal for Parasitology

6 August 2017

1 reference

6 August 2017

33

1 reference

6 August 2017

5-6

1 reference

6 August 2017

469-478

1 reference

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Adjuvants designed for veterinary and human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

ISCOMs and other saponin based adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Vaccine delivery to animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Oral vaccination in man using antigens in particles: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Adjuvant activity of incomplete Freund's adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Influence of antigens and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Seeking wisdom in innate immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

The instructive role of innate immunity in the acquired immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

A protein particle vaccine containing multiple malaria epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Action of Saponin on Biological Cell Membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Skin immunization made possible by cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Transcutaneous immunization: a human vaccine delivery strategy using a patch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immunological adjuvants: a role for liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Approaching the asymptote? Evolution and revolution in immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

CpG motifs as immune adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

The identification of plant lectins with mucosal adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Tolerance, danger, and the extended family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

An innate sense of danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Innate immunity: the virtues of a nonclonal system of recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Development of adjuvant-active nonionic block copolymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Controlled release microparticles for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Improving protein therapeutics with sustained-release formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Production of hepatitis B surface antigen in transgenic plants for oral immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Cationic microparticles: A potent delivery system for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Cationic microparticles are an effective delivery system for immune stimulatory cpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immune responses to ISCOM formulations in animal and primate models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Lipopeptide particles as the immunologically active component of CTL inducing vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7519%2803%2900053-5

7 January 2021

10.1016/S0020-7519(03)00053-5

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12782048